Cross Country Healthcare, Inc. (NASDAQ:CCRN - Get Free Report) has received an average recommendation of "Hold" from the six research firms that are currently covering the stock, MarketBeat Ratings reports. Six research analysts have rated the stock with a hold rating. The average 12 month target price among brokerages that have updated their coverage on the stock in the last year is $17.93.
A number of research analysts have commented on the company. Barrington Research restated a "market perform" rating and issued a $18.61 target price on shares of Cross Country Healthcare in a research note on Tuesday, June 17th. Wall Street Zen upgraded Cross Country Healthcare to a "hold" rating in a report on Saturday, August 9th.
Read Our Latest Stock Report on Cross Country Healthcare
Cross Country Healthcare Stock Performance
Shares of NASDAQ CCRN traded down $0.17 during mid-day trading on Friday, reaching $13.37. The company had a trading volume of 267,620 shares, compared to its average volume of 408,540. The company has a market capitalization of $438.00 million, a price-to-earnings ratio of -51.42, a PEG ratio of 8.08 and a beta of 0.38. The stock has a fifty day moving average of $13.26 and a two-hundred day moving average of $13.68. Cross Country Healthcare has a 12-month low of $9.58 and a 12-month high of $18.33.
Cross Country Healthcare (NASDAQ:CCRN - Get Free Report) last released its earnings results on Wednesday, August 6th. The business services provider reported ($0.01) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.07 by ($0.08). The company had revenue of $274.07 million during the quarter, compared to analysts' expectations of $292.67 million. Cross Country Healthcare had a positive return on equity of 1.72% and a negative net margin of 0.70%. Sell-side analysts forecast that Cross Country Healthcare will post 0.53 earnings per share for the current fiscal year.
Institutional Trading of Cross Country Healthcare
A number of institutional investors and hedge funds have recently made changes to their positions in CCRN. Signaturefd LLC increased its holdings in shares of Cross Country Healthcare by 139.9% during the 2nd quarter. Signaturefd LLC now owns 2,193 shares of the business services provider's stock valued at $29,000 after acquiring an additional 1,279 shares during the last quarter. BNP Paribas Financial Markets grew its holdings in Cross Country Healthcare by 50.0% during the second quarter. BNP Paribas Financial Markets now owns 3,424 shares of the business services provider's stock valued at $45,000 after purchasing an additional 1,142 shares during the last quarter. Tower Research Capital LLC TRC raised its position in shares of Cross Country Healthcare by 422.0% in the second quarter. Tower Research Capital LLC TRC now owns 3,586 shares of the business services provider's stock valued at $47,000 after purchasing an additional 2,899 shares during the period. Longfellow Investment Management Co. LLC acquired a new stake in shares of Cross Country Healthcare in the first quarter worth $59,000. Finally, AlphaQuest LLC grew its stake in Cross Country Healthcare by 324.6% in the 1st quarter. AlphaQuest LLC now owns 8,297 shares of the business services provider's stock valued at $124,000 after buying an additional 6,343 shares during the last quarter. Institutional investors and hedge funds own 96.03% of the company's stock.
Cross Country Healthcare Company Profile
(
Get Free Report)
Cross Country Healthcare, Inc provides talent management and other consultative services for healthcare clients in the United States. The company's Nurse and Allied Staffing segment provides traditional staffing, recruiting, and value-added total talent solutions, including temporary and permanent placement of travel and local nurse and, allied professionals; temporary placement of healthcare leaders within nursing, allied, physician, and human resources; vendor neutral and managed services programs; education healthcare services; in-home care services; and outsourcing services.
Further Reading

Before you consider Cross Country Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cross Country Healthcare wasn't on the list.
While Cross Country Healthcare currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.